Qiagen NV (NYSE: QGEN) on Tuesday, plunged -0.82% from the previous trading day, before settling in for the closing price of $43.65. Within the past 52 weeks, QGEN’s price has moved between $39.03 and $47.44.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 6.29% annually for the last half of the decade. The company achieved an average annual earnings per share of 3.95%. With a float of $221.23 million, this company’s outstanding shares have now reached $222.26 million.
In an organization with 5967 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 49.66%, operating margin of 5.92%, and the pretax margin is 5.81%.
Qiagen NV (QGEN) Insider Updates
Observing investor behavior towards Diagnostics & Research industry stocks is more important than anything else. The insider ownership of Qiagen NV is 0.28%, while institutional ownership is 78.72%. The most recent insider transaction that took place on Sep 11 ’24, was worth 1,150,000.
Qiagen NV (QGEN) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 3.95% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.21% during the next five years compared to 12.66% growth over the previous five years of trading.
Qiagen NV (NYSE: QGEN) Trading Performance Indicators
Qiagen NV (QGEN) is currently performing well based on its current performance indicators. A quick ratio of 1.89 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.88. Likewise, its price to free cash flow for the trailing twelve months is 20.72.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.40, a number that is poised to hit 0.60 in the next quarter and is forecasted to reach 2.29 in one year’s time.
Technical Analysis of Qiagen NV (QGEN)
Let’s dig in a bit further. During the last 5-days, its volume was 0.69 million. That was inferior than the volume of 1.15 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 83.71%. Additionally, its Average True Range was 0.75.
During the past 100 days, Qiagen NV’s (QGEN) raw stochastic average was set at 41.47%, which indicates a significant decrease from 79.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 20.48% in the past 14 days, which was lower than the 21.47% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $43.19, while its 200-day Moving Average is $43.41. However, in the short run, Qiagen NV’s stock first resistance to watch stands at $43.75. Second resistance stands at $44.22. The third major resistance level sits at $44.45. If the price goes on to break the first support level at $43.05, it is likely to go to the next support level at $42.82. Assuming the price breaks the second support level, the third support level stands at $42.35.
Qiagen NV (NYSE: QGEN) Key Stats
Market capitalization of the company is 9.60 billion based on 228,203K outstanding shares. Right now, sales total 1,965 M and income totals 341,300 K. The company made 501,870 K in profit during its latest quarter, and 98,060 K in sales during its previous quarter.
